The Endocrine Society now issued a Clinical Practice Guideline (CPG) advising against the use of testosterone treatment in healthy women. Although the FDA approved testosterone therapy for the treatment of diseases affecting the testes, pituitary and hypothalamus, it has not been approved for treating age-related declines in testosterone levels. The U.S. National Institute on Aging is also expected to release the results of research on the safety of testosterone. The study included about 800 elderly men with low testosterone and symptoms related to this ailment, for example http://tinyurl.com/jkhvqy9
sexual and physical dysfunction. Since the heart health of the men was monitored, the research is expected to shed more light on the safety of testosterone therapy.
Research has shown that testosterone deficiency
is associated with a number of significant health problems like obesity, diabetes, metabolic syndrome, and bone fractures Men who meet medical criteria for treatment should get therapy. The truth is, your testosterone levels have likely been slowly declining for quite some time, a decline that usually begins around age 30.
And many girls have a knee-jerk suspicion that any hormone treatment can increase their risk of breast cancer. Nevertheless, clinical studies show that testosterone not only doesn't raise a woman's risk of breast cancer , it may play a vital role in warding off the disease. Glaser thinks this will probably stay the status quo for a little while, given the prohibitive cost of running the long term safety studies needed to gain FDA approval that is more total.